Rathbones Group PLC Amgen Inc Transaction History

Rathbones Group PLC

$19 Billion
Q3 2024

A detailed history of Rathbones Group PLC transactions in Amgen Inc stock. As of the latest transaction made, Rathbones Group PLC holds 11,866 shares of AMGN stock, worth $3.13 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

11,866

Previous 11,774 0.78%

Holding current value

$3.13 Million

Previous $3.68 Million 3.94%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$309.38 - $337.38 $28,462 - $31,038	92 Added 0.78%	11,866 $3.82 Million
Q2 2024 Aug 09, 2024	BUY	$262.75 - $319.31 $539,688 - $655,862	2,054 Added 21.13%	11,774 $3.68 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $163,472 - $197,332	608 Added 6.67%	9,720 $2.76 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $47,048 - $53,076	184 Added 2.06%	9,112 $2.62 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $175,357 - $217,710	802 Added 9.87%	8,928 $2.4 Million
Q2 2023 Aug 04, 2023	SELL	$214.27 - $253.37 $7.5 Million - $8.87 Million	-35,000 Reduced 81.16%	8,126 $1.8 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $970,897 - $1.18 Million	-4,300 Reduced 9.07%	43,126 $10.4 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $10.6 Million - $13.4 Million	-46,151 Reduced 49.32%	47,426 $12.5 Million
Q3 2022 Nov 03, 2022	SELL	$224.46 - $253.15 $6.54 Million - $7.37 Million	-29,122 Reduced 23.73%	93,577 $21.1 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $253,781 - $282,414	-1,100 Reduced 0.89%	122,699 $29.9 Million
Q1 2022 May 11, 2022	BUY	$219.27 - $242.57 $1.02 Million - $1.13 Million	4,665 Added 3.92%	123,799 $29.9 Million
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $755,744 - $864,880	3,800 Added 3.29%	119,134 $26.8 Million
Q3 2021 Nov 04, 2021	BUY	$212.27 - $248.7 $275,101 - $322,315	1,296 Added 1.14%	115,334 $24.5 Million
Q2 2021 Jul 30, 2021	BUY	$233.58 - $259.14 $3.28 Million - $3.64 Million	14,055 Added 14.06%	114,038 $27.8 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $955,766 - $1.11 Million	4,307 Added 4.5%	99,983 $24.9 Million
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $1.97 Million - $2.35 Million	9,121 Added 10.54%	95,676 $22 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $550,254 - $611,927	2,345 Added 2.78%	86,555 $22 Million
Q2 2020 Aug 07, 2020	BUY	$197.81 - $242.74 $1.3 Million - $1.6 Million	6,572 Added 8.46%	84,210 $19.9 Million
Q1 2020 May 04, 2020	BUY	$182.24 - $241.7 $1.82 Million - $2.41 Million	9,980 Added 14.75%	77,638 $15.7 Million
Q4 2019 Feb 11, 2020	SELL	$189.21 - $243.2 $4.29 Million - $5.52 Million	-22,680 Reduced 25.11%	67,658 $16.3 Million
Q3 2019 Nov 13, 2019	BUY	$174.11 - $208.62 $5.08 Million - $6.09 Million	29,193 Added 47.74%	90,338 $17.5 Million
Q2 2019 Aug 12, 2019	SELL	$166.7 - $195.41 $5,334 - $6,253	-32 Reduced 0.05%	61,145 $11.3 Million
Q1 2019 May 09, 2019	SELL	$180.87 - $203.88 $1.08 Million - $1.21 Million	-5,952 Reduced 8.87%	61,177 $11.6 Million
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $83,491 - $97,461	468 Added 0.7%	67,129 $13.1 Million
Q3 2018 Oct 12, 2018	SELL	$185.29 - $208.89 $67,074 - $75,618	-362 Reduced 0.54%	66,661 $13.8 Million
Q2 2018 Jul 16, 2018	BUY	$166.05 - $186.51 $884,880 - $993,911	5,329 Added 8.64%	67,023 $12.4 Million
Q1 2018 Apr 06, 2018	BUY	$169.43 - $198.0 $964,903 - $1.13 Million	5,695 Added 10.17%	61,694 $10.5 Million
Q4 2017 Jan 24, 2018	BUY	$168.79 - $188.59 $359,185 - $401,319	2,128 Added 3.95%	55,999 $9.74 Million
Q3 2017 Oct 24, 2017	BUY	$167.29 - $191.0 $9.01 Million - $10.3 Million	53,871	53,871 $10 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rathbones Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Rathbones Group PLC with notifications on news.

Account

Rathbones Group PLC Amgen Inc Transaction History